97福利网_91免费视频在线_91国在线高清视频_91麻豆精品国产91久久久资源速度_国产网站久久_素人视频免费观看

关注 >   >  正文

刘振洋教授:2023 ESMO WCGIC精彩回顾,胃癌靶向治疗迎来新突破

评论


(资料图片)

湖南省肿瘤医院消化泌尿内一科主任

主任医师,医学博士,博士后

湖南省医学会消化肿瘤内科学组组长

湖南省抗癌协会肿瘤靶向治疗专委会主任委员

湖南省抗癌协会大肠癌专委会副主任委员

湖南省抗癌协会家族遗传性肿瘤专委会副主任委员

湖南省医促会恶性肿瘤精准与综合诊疗专委会副主任委员

[2]L. Shen, D. Liu, N. Li,et al. Osemitamab in combination with capecitabine and oxaliplatin (CAPOX) as a first line treatment of advanced G/GEJ cancer: Updated data of cohort C from a phase I/IIa, multi-center study (TranStar102/TST001-1002). 2023 ESMO WCGIC. Abstract PD-7.[3]Z. Wainberg, Y. Kang, K. Lee, et al. Bemarituzumab for treatment of previously untreated advanced and/or metastatic gastric and gastroesophageal cancer (GC): Final analysis of a randomized phase 2 trial (FIGHT). 2023 ESMO WCGIC. Abstract SO-11.[4]T. Satoh, P. Barthélémy, L. Nogova, et al. Phase 2 Study of Futibatinib in Patients With Specific FGFR Aberrations: Activity in Patients With Gastric or Gastroesophageal Junction Cancer Harboring FGFR2 Amplification. 2023 ESMO WCGIC. Abstract SO-10.[5]Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010 Aug 28;376(9742):687-97.[6]Hofheinz R , Hegewischbecker S , Thusspatience P C , et al. HER-FLOT: Trastuzumab in combination with FLOT as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study Group.2014 ASCO. Abstract 4073.[7]Shitara K, Lordick F, Bang YJ, et al. Zolbetuximab + mFOLFOX6 as first-line (1L) treatment for patients (pts) with claudin-18.2+ (CLDN18.2+) / HER2? locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary results from phase 3 SPOTLIGHT study. 2023 ASCO GI. Abstract LBA292.[8]Xu Rh, Shitara K, Ajani JA, Zolbetuximab + CAPOX in 1L claudin-18.2+ (CLDN18.2+)/HER2? locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW. 2023 ASCO GI. Abstract 405736.[9]Kohei Shitara, Rui-Hua Xu, Diarmuid Martin Moran, et al. Global prevalence of CLDN18.2 in patients with locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Biomarker analysis of two zolbetuximab phase 3 studies (SPOTLIGHT and GLOW). 2023 ASCO. Abstract 4035.本材料由阿斯利康提供,仅供医疗卫生专业人士进行医学科学交流,不用于推广目的审批编号:CN-120160 过期日期:2024-2-9

* 此文仅用于向医学人士提供科学信息,不代表本平台观点

标签:

今日热点

热点排行

最近更新

所刊载信息部分转载自互联网,并不代表本网赞同其观点和对其真实性负责。邮箱:5855973@qq.com

联系我们| 中国品牌网 | 沪ICP备2022005074号-18 营业执照  Copyright © 2018@. All Rights Reserved.

主站蜘蛛池模板: 免费中国一级啪啪片 | 亚洲精品国产国语 | 黄视频在线观看免费 | 久久精品91| 成人免费观看在线视频 | 97狠狠| 黑丝国产 | 最近中文字幕视频完整版在线看 | 图片区小说区另类春色 | 中国真实处破女www出血 | 亚洲国产一区二区三区青草影视 | 亚洲欧美日本a∨在线观看 亚洲欧美日本国产 | 国模娜娜一区二区三区 | 精品亚洲成av人在线观看 | 美女视频黄a视频免费全过程在线 | 香蕉视频免费版 | 福利一区在线视频 | 免费国产黄网站在线观看动图 | 亚洲精品www久久久久久 | 精品四虎免费观看国产高清午夜 | 亚洲欧美日韩中文综合在线不卡 | 天天干天天拍 | 国产综合视频在线观看 | 久久九九精品一区二区 | 最近中文字幕最新在线视频 | 欧美第一色 | 久久久亚洲欧洲日产国码农村 | 精品无码一区在线观看 | 4hu四虎永久免在线视 | 成人毛片免费在线观看 | 伊人久久大香线蕉综合电影网 | 青青草在线免费 | 久久久亚洲色 | 99精品国产成人a∨免费看 | 国产免费av片在线观看播放 | 毛片免费的 | 久久er国产精品免费观看8 | 欧美日韩一区二区三区在线 | 国产在线看不卡一区二区 | 免费的黄色的视频 | 日本伦理电影网址 |